NCM
Nantahala Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Buy |
4,367,438
+558,877
| +15% | +$4.52M | 1.38% | 8 |
|
|
2025
Q1 | $31.9M | Buy |
3,808,561
+143,032
| +4% | +$1.2M | 1.27% | 7 |
|
|
2024
Q4 | $29M | Buy |
3,665,529
+995,586
| +37% | +$7.89M | 1.25% | 10 |
|
|
2024
Q3 | $22.2M | Hold |
2,669,943
| – | – | 1.12% | 11 |
|
|
2024
Q2 | $17M | Buy |
2,669,943
+50,000
| +2% | +$318K | 0.99% | 13 |
|
|
2024
Q1 | $15.9M | Buy |
2,619,943
+285,546
| +12% | +$1.73M | 0.91% | 17 |
|
|
2023
Q4 | $14.2M | Buy |
2,334,397
+121,640
| +5% | +$738K | 0.85% | 19 |
|
|
2023
Q3 | $9.34M | Buy |
2,212,757
+63,452
| +3% | +$268K | 0.8% | 25 |
|
|
2023
Q2 | $6.66M | Buy |
2,149,305
+1,649,305
| +330% | +$5.11M | 0.64% | 34 |
|
|
2023
Q1 | $695K | Buy |
+500,000
| New | +$695K | 0.05% | 88 |
|